유전자 독성 검사 시장 규모, 점유율, 성장 분석 : 검사 방법별, 제품별, 어세이 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Genetic Toxicology Testing Market Size, Share, and Growth Analysis, By Testing Methodology (In Vitro Testing, In Vivo Testing), By Product (Reagents & Consumables, Assay Kits), By Assay Type, By End User, By Region - Industry Forecast 2025-2032
상품코드:1663118
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유전자 독성 검사 시장 규모는 2023년에 15억 8,000만 달러로 평가되며, 2024년 17억 7,000만 달러에서 2032년에는 43억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.8%로 성장할 전망입니다.
유전자 독성 테스트 시장은 제약, 생명공학, 화학 분야에서 신약, 화학물질, 소비자 제품의 종합적인 안전성 평가를 보장하기 위해 점점 더 중요해지고 있습니다. 규제 당국의 요구 사항 증가, 시험 방법의 발전, 건강과 안전에 대한 사회적 관심 증가로 인해 이 시장은 크게 성장하고 있습니다. 주요 성장 촉진요인으로는 의약품 및 화학물질에 대한 연구개발 활동 증가, 전 세계 보건 당국의 엄격한 규제, 유전독성 물질과 관련된 장기적 위험에 대한 인식 증가 등을 들 수 있습니다. Ames 시험과 같은 전통적인 방법이 여전히 중요하지만, in vitro 소핵 시험이나 하이스루풋 스크리닝과 같은 혁신적 기술로 강화되고 있습니다. 이러한 비동물 시험 모델로의 진화는 윤리적 기준에 부합하며, 시장 성장을 가속하고 이 분야를 전문으로 하는 주요 기업 및 위탁 연구 기관의 서비스 제공의 폭을 넓혀주고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 상황
특허 분석
유전자 독성 검사 시장 규모 : 검사 방법별 & CAGR(2025-2032)
시장 개요
in vitro 시험
생체내 검사
계산 독성학
High Throughput Screening
유전자 독성 검사 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
시약·소모품
어세이 키트
서비스
유전자 독성 검사 시장 규모 : 어세이 유형별 & CAGR(2025-2032)
시장 개요
에임즈 시험
소핵 시험
혜성 시험
염색체 이상 검사
유전자 독성 검사 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
제약회사
조사기관
계약 조사기관(CRO)
정부기관
유전자 독성 검사 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific Inc.(USA)
Charles River Laboratories International, Inc.(USA)
Laboratory Corp of America Holdings(USA)
Eurofins Scientific(Germany)
Jubilant Life Sciences Limited(India)
Merck KGaA(Germany)
Toxikon Corporation(USA)
Gentronix Limited(UK)
WuXi AppTec(China)
Inotiv Inc.(USA)
Creative Bioarray(USA)
MB Research Laboratories(USA)
Molecular Toxicology Inc.(USA)
Toxys(Netherlands)
Syngene International Limited(India)
GeneTox Worldwide Inc.(USA)
Scantox Group(Denmark)
Covance Inc.(USA)
BioReliance Corporation(USA)
Envigo(USA)
결론과 제안
KSA
영문 목차
영문목차
Genetic Toxicology Testing Market size was valued at USD 1.58 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 4.31 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).
The genetic toxicology testing market is increasingly pivotal in the pharmaceutical, biotechnology, and chemical sectors, ensuring comprehensive safety assessments of new drugs, chemicals, and consumer products. With rising regulatory demands, advancements in testing methodologies, and a growing public focus on health and safety, this market is witnessing significant expansion. Key growth drivers include intensified research and development activities in pharmaceuticals and chemicals, strict regulations from global health authorities, and rising awareness of the long-term risks associated with genotoxic substances. While traditional methods like the Ames test remain vital, they are being enhanced by innovative techniques such as in vitro micronucleus assays and high-throughput screening. This evolution towards non-animal testing models is in line with ethical standards, facilitating market growth and broadening the service offerings of key players and contract research organizations specializing in this field.
Top-down and bottom-up approaches were used to estimate and validate the size of the Genetic Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region. Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening. Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services. Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test. Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Genetic Toxicology Testing Market
A key factor propelling the growth of the Genetic Toxicology Testing market is the increasing awareness among both individuals and healthcare professionals regarding the significance of genetic health and its implications. This heightened understanding underscores the importance of genetic toxicology testing, which plays a crucial role in identifying potential risks linked to environmental exposures, including chemicals, pharmaceuticals, and pollutants. By providing insights into these risks, genetic toxicology testing facilitates personalized healthcare approaches and promotes preventive strategies, ultimately contributing to better health outcomes and enhancing public awareness of genetic considerations in health management.
Restraints in the Genetic Toxicology Testing Market
The Genetic Toxicology Testing market faces significant restraints due to ethical concerns associated with the analysis of genetic information. Issues surrounding privacy, informed consent, and the potential for misuse of personal data present major challenges. The meticulous collection, storage, and application of genetic data necessitate compliance with stringent privacy regulations, which can serve as a barrier to the broad acceptance and implementation of this testing in various sectors. Consequently, these ethical and regulatory dilemmas may impede the growth of the market, limiting its potential benefits and prompting cautious engagement from both providers and consumers.
Market Trends of the Genetic Toxicology Testing Market
The genetic toxicology testing market is experiencing a pronounced trend towards in vitro testing methods, reflecting a broader shift in regulatory and scientific practices. Traditional animal models are progressively being supplanted by cell-based assays that not only alleviate ethical concerns but also enhance the speed and cost-efficiency of testing processes. Prominent in this transition are in vitro techniques such as the Ames test, micronucleus assay, and Comet assay, which demonstrate a strong correlation with human biology and offer reliable assessments of genotoxicity and mutagenicity. This trend is further reinforced by the endorsement from regulatory agencies advocating for more humane and efficient testing methodologies, propelling the accelerated adoption of these innovative approaches across the industry.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Global Genetic Toxicology Testing Market Size by Testing Methodology & CAGR (2025-2032)
Market Overview
In Vitro Testing
In Vivo Testing
Computational Toxicology
High-Throughput Screening
Global Genetic Toxicology Testing Market Size by Product & CAGR (2025-2032)
Market Overview
Reagents & Consumables
Assay Kits
Services
Global Genetic Toxicology Testing Market Size by Assay Type & CAGR (2025-2032)
Market Overview
Ames Test
Micronucleus Test
Comet Assay
Chromosomal Aberration Test
Global Genetic Toxicology Testing Market Size by End User & CAGR (2025-2032)
Market Overview
Pharmaceutical Companies
Research Institutions
Contract Research Organizations (CROs)
Government Agencies
Global Genetic Toxicology Testing Market Size & CAGR (2025-2032)
North America (Testing Methodology, Product, Assay Type, End User)
US
Canada
Europe (Testing Methodology, Product, Assay Type, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Testing Methodology, Product, Assay Type, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Testing Methodology, Product, Assay Type, End User)
Brazil
Rest of Latin America
Middle East & Africa (Testing Methodology, Product, Assay Type, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Thermo Fisher Scientific Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Charles River Laboratories International, Inc. (USA)
